Object. Infiltrative tumor resection is based on regional (macroscopic) imaging identification of tumorous tissue and the attempt to delineate invasive tumor margins in macroscopically normal-appearing tissue, while preserving normal brain tissue. The authors tested miniaturized confocal fiberoptic endomicroscopy by using a near-infrared (NIR) imaging system with indocyanine green (ICG) as an in vivo tool to identify infiltrating glioblastoma cells and tumor margins.
ach year in the US, approximately 16,000 new brain tumors are diagnosed in adults. 26 Cytoreduction, verification of the histological diagnosis, and identification of tumor invasion in macroscopically normal-appearing tissue are crucial to predict prognosis in the resection of malignant gliomas.
14 Complete resection of brain tumors is more demanding than for any other organ system, and is often precluded by the infiltration of tumor cells into the brain and the concomitant need to preserve brain tissue. Furthermore, differentiating among gliosis, radiation effects, and tumor-containing tissue after a recurrence can be difficult. Because tumor resection is based on macroscopic identification of the tumor region, complete resection and clearance of surgical margins can seldom be achieved. Compared with permanent sections, frozen sections obtained from small biopsy specimens often do not reveal the histological features needed for final diagnosis. This limitation reflects factors such as frozen section artifact, sampling error, and time restrictions. The use of such sampling to guide resection is impractical.
Because intraoperative methods of detection are based on the macroscopic level, the tumor mass cannot be characterized at a cellular level, nor can the exact tumor margin be determined. Despite significant improvements in intraoperative ultrasonography, the reliability of this modality is inferior to that of intraoperative MR imaging for detecting tumor remnants. 8, 21 However, the cost of intraoperative MR imaging is prohibitive, and observations of the completeness of resection are limited when shifting of the intracranial contents distorts the anatomy. An optimal imaging technique would allow intraoperative identification of regions containing tumor and their microscopic extent, producing real-time data that enhance surgical decisions without significantly prolonging anesthesia and operating times.
Fluorescence imaging approaches to these challenges have been developed. Clinical grade fluorescent contrast agents available for in vivo fluorescence imaging of the brain are limited. The VWF (especially fluorescein sodium) techniques have been evaluated extensively with in vivo confocal microscopy of humans-in gastrointestinal and gynecological endoscopic and laparoscopic applications and, most recently, in neurosurgery. 12, 19 Recently, 5-ALA has been used for VWF imaging at operating microscope magnification during glioma surgery.
22
Compared with VWF for confocal microscopy, NIR excitation offers increased imaging depth. An NIR wavelength contrast medium, ICG, is used for video angiography performed with commercially available surgical microscopes equipped with appropriate optics. When used for macroscopic delineation of tumor margins, ICG has demonstrated encouraging specificity for tissue containing tumor, but the requisite timed measurements interrupt the surgical workflow and preclude rapid screening of multiple observational fields. 10, 11 Recently, a miniaturized confocal endomicroscope was developed for NIR imaging of ICG, and its use was reported for in vivo imaging of human liver steatosis and fibrosis. 9 However, NIR confocal microscopy of ICG has not yet been assessed for intraoperative microscopic detection of cancer. We therefore tested the utility of intraoperative ICG confocal endomicroscopy as a tool for identifying infiltrating brain tumor cells and tumor margins.
Methods

Experimental Animals
Female B6 (Cg)-Tyr c-2 J /J (albino variant of C57BL/6) mice (10-12 weeks old) were obtained from The Jackson Laboratory. The mice were kept in the animal care facility of St. Joseph's Hospital and Medical Center, in rooms with controlled temperature and humidity under a 12-hour light-dark cycle. The animals were provided with standard rodent chow and free access to water. Experiments were performed in accordance with the guidelines and regulations set forth by the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee of the BNI and St. Joseph's Hospital and Medical Center.
Brain Tumor Model
The GL261 cell line was obtained from the Division of Cancer Treatment and Diagnosis of the National Cancer Institute. This GL261 cell line was created from a mouse brain tumor originally induced by intracranial injection of 3-methyl-cholantrene into the C57BL/6 syngeneic mouse strain. 28 The morphological, biochemical, and growth characteristics of the GL261 mouse brain tumor model are described elsewhere, and it has emerged as the gold standard syngeneic model for experimental aggressive glioma work. 3, 23 To facilitate a quantitative measurement of tumor growth rate, GL261 cells were made bioluminescent by using the Lentiphos HT System with the Lenti-X HT Packaging Mix (both from Clontech Laboratories, Inc.) and the FUW-GL plasmid (a generous gift from the laboratory of Dr. J.B. Rubin, Washington University, St. Louis, MO). The resulting GL261-luc cells were grown in DMEM (Invitrogen Corp.) supplemented with 10% tetracycline-free fetal calf serum (Clontech Laboratories, Inc.) at 37°C with 5% CO 2 . Cultured cells were harvested by trypsinization, washed once in phosphate-buffered saline (Invitrogen Corp.), and resuspended in DMEM without serum at a concentration of 10 7 cells/ml.
Intracranial Implantation
Animals were anesthetized by intraperitoneal injection of a mixture of 10 mg/kg xylazine and 80 mg/ kg ketamine (Wyeth LLC) and placed in a small-animal stereotactic headframe (model 900; David Kopf Instruments). A 10-mm incision was made starting between the animal's eyes, exposing the bregma. A bur hole was made 0.1 mm posterior to the bregma and 2.3 mm right of the midline. The GL261 cells were infused at a depth of 2.0 mm below the surface of the brain after the syringe (World Precision Instruments, Inc.) was advanced 2.5 mm to create a 0.5-mm pocket. The cell suspension was infused over 3 minutes with the aid of a UMP3-1 UltraMicroPump microinjector (World Precision Instruments, Inc.) set to a volume of 2 μl, with an infusion rate of 0.67 μl/minute. The needle was withdrawn 2 minutes after the injection to minimize backflow of the cell suspension. The bur hole was covered with bone wax and the skin incision was sutured.
Tumor Growth
Intracranial tumor growth was analyzed by in vivo bioluminescent imaging for which an IVIS Spectrum in vivo imaging system (Caliper Life Sciences) was used. Animals were injected subcutaneously with luciferin (15 mg/ml in phosphate-buffered saline, 150 μg luciferin/kg body weight; Caliper Life Sciences) 20 minutes before imaging. Animals were anesthetized with isoflurane and maintained at 37°C under isoflurane anesthesia during the imaging process. Tumor cells were detectable from the day of implantation, and quantitation was done using the imaging system's Living Image 3.1 software. Quantitative measurements of the tumor burden were reproducible in that they rose steadily until the 14th day after implantation (Fig. 1) . However, growth curves mostly depended on the state of implanted cells, unavoidable minor variability in the implantation procedure, or both.
Animal Surgery
On the 14th day after implantation, mice were anesthesized using the xylazine/ketamine mixture as described previously. A craniectomy was performed to expose the convex surfaces of both cerebral hemispheres. Intraoperative imaging was then performed. Oxygen supply and body temperature were maintained during the procedure. Intraparenchymal brain tumors were macroscopically identified in the right hemisphere of all implanted mice. Successful hemostasis was achieved throughout the procedure with saline irrigation. At the end of each experiment, anesthetized animals were killed according to our institutional guidelines.
Study Design
This study was conducted in 2 main phases. The purpose of the first phase was to validate the use of ICG fluorescence in both intraoperative NIR macroscopic and miniaturized confocal endomicroscopic techniques for the identification of brain tumors in the mouse model. The first phase of the experiment was conducted in 18 mice. Several intraoperative fluorescence macroscopic video loops, confocal images, and histological specimens were collected and analyzed from each mouse. The second phase was conducted to determine the timing characteristics of brain tumor saturation with ICG, both macro-and endomicroscopically. Two groups of animals were used in the second phase: in Group 1, 6 mice were used for intraoperative fluorescence macroscopy; and in Group 2, 6 mice were used for intraoperative confocal endomicroscopy.
Phase 1
Intraoperative Fluorescence Macroscopy. A neurosurgical microscope with built-in NIR video angiography technology (Zeiss OPMI Pentero; Carl Zeiss Surgical GmbH) was used for intraoperative macroscopic imaging. The device integrates NIR imaging into the surgical microscope, capturing high-resolution NIR images based on ICG fluorescence without eliminating visible light during the entire surgical intervention (range of magnification 1.2-14.6). 16 Once exposed, the mouse brain was illuminated by the NIR light emitted from the surgical microscope. An optical filter built into the microscope imaging system blocked both ambient and excitation light so that only ICG-induced fluorescence was captured. Immediately after intravenous injection, ICG fluorescence could be observed in major vessels (Fig. 2) .
Intraoperative Confocal Endomicroscopy. Intraoperative confocal endomicroscopy was accomplished using a prototype handheld instrument in which a miniaturized scanner has been integrated into a rigid probe with a 6.3-mm outer diameter and a length of 150 mm (Optiscan Pty. Ltd.). A 780-nm diode laser provided incident excitation light, and fluorescent emission was detected at > 795 nm by using a long-pass filter, via a single optical fiber acting as both the excitation and detection pinholes for confocal isolation of the focal plane. The detector signal was digitized synchronously with the scanning to construct images parallel to the tissue surface (en face optical sections). Laser power was typically set to 550-900 μW for brain tissue; maximum power was limited to 2000 μW. An FOV of 475 × 475 μm (magnification approximately 1000 on a 21-inch screen) was scanned at 1024 × 512 pixels (at 1.2/second frame rate) or at 1024 × 1024 pixels (0.7/ second frame rate). The resulting images were stored digitally and could be recorded in continuous sequences for replay as video loops. During the procedure, a foot pedal After ICG was injected, the miniaturized probe affixed to the stereotactic head frame was moved gently along the surface of the brain tissue to obtain images from several ROIs. The ROIs included normal brain and regions of obvious tumor in addition to the transitional zone between normal brain and tumor. The mechanical shaft of the stereotactic frame was used to move the probe smoothly between different ROIs without losing contact with the tissue. Several images were acquired from each ROI at the surface and at increasing depths of the tissue. Unique aspects of individual cells and other surrounding tumor tissue were seen as the endomicroscopic probe imaged throughout its focal depth range. The total imaging time was approximately 40 minutes per mouse with the animal in optimal physiological status.
Tissue Sampling, Histological Assessment, and Data Processing. Multiple biopsy samples were harvested from each mouse. Brain tissues slices (0.5 cm 2 ) containing several ROIs were cut manually parallel to the surface. Areas that were imaged using a confocal endomicroscope were marked with tissue ink (Pathmark; BBC Biochemical Corp.) so that precise locations of confocal endomicroscopic imaging could be validated with conventional histological studies. The tissue was placed in a cassette for standard formalin fixation and paraffin embedding. Histological assessment was performed using standard light microscopic evaluation of 10-μm-thick H & E-stained sections. Careful labeling and grouping of acquired confocal images and specific biopsy samples ensured correct correlation. Image sequences were collated into video loops, and confocal images were evaluated using ImageJ software (supplemental video: Rasband, W.S. 
Phase 2
Mice from both groups were imaged for 15 minutes after the ICG was injected. Continuous video recording performed using both white light and NIR modes allowed the kinetics of macroscopic tumor size and fluorescence to be assessed in the first group. Mice from the second group underwent intraoperative confocal endomicroscopy, with the miniaturized probe being placed above obvious tumor tissue. Images were acquired from the same ROI in a sequential fashion over 15 minutes, and data from different time points were compared (Fig. 3) .
Results
Phase 1
Applying the confocal probe to normal-appearing brain distant from the tumor revealed a predominantly intravascular distribution of ICG; strongly contrasting, bright, small vessels; and capillary networks over a dark extravascular background. Extravascular ICG staining was distributed sparsely among uniformly shaped cell bodies that were morphologically consistent with the histological features of normal brain tissue (Fig. 4) . Erythrocyte streaming was observed in vessels during continuous imaging.
Within obvious tumor tissue, images were dominated by extravascular ICG concentrated in clusters of cellular structures showing hypercellularity, pleomorphism, and mitoses, which were morphologically consistent with cytoplasmic labeling of tumor cells (Fig. 5) . Other regions presented a complex mixture of these patterns, with mostly normal-appearing brain punctuated by large pleomorphic cells consistent with an infiltrative margin, or satellite tumor cell clusters surrounded by brain tissue. In brain tissue next to the tumor, which appeared normal macroscopically as viewed via the surgical microscope, patterns consistent with tumor morphological features were also seen (Fig. 6) . Critically, individual tumor cells within brain tissue could be identified within the 475 × 475-μm FOV, and a definitive tumor border or invading cells could be delimited (Figs. 4-6 ).
Phase 2
Immediately after ICG injection, fluorescence was seen in only a few clusters of tumor cells. Fifteen minutes later, the entire tumor mass was saturated with ICG expressing bright fluorescence of tumor cells. Interestingly, some regions of focal brightness viewed in fluorescent mode under a surgical microscope were morphologically consistent with normal brain on confocal endomicroscopy, mostly representing leakage of ICG related to surgical trauma (Fig. 2) .
Discussion
This study describes the first in vivo application of NIR confocal endomicroscopy for examining infiltrative cancer (that is, a malignant glioma) by using ICG fluorescence. Tumor cells, different tumor regions, and normal brain tissue and microvasculature were detected reliably. Intraoperative confocal endomicroscopy of ICG distribution revealed striking microvascular, cellular, and subcellular structures in various tumor regions that correlated with conventional histological features and known tissue architecture in real time during ongoing surgery. These results suggest that NIR in vivo confocal endomicroscopy is a potentially important tool for intraoperative tumor detection on the cellular level and for histopathological diagnosis, providing instant feedback during glioma surgery.
Miniaturized Confocal Microscope Technology in a Handheld Device
Miniaturization of confocal microscope technology into a small endomicroscope allows in vivo detection of tissue cytoarchitecture by using a handheld fiberoptic device. Visible-wavelength confocal endomicroscopy has been widely implemented in gastroenterology, gynecology, pulmonology, and urology. 7, 20, 24, 25 It has been shown to be a reliable, instant diagnostic technique, providing a significantly increased diagnostic yield of histological sampling and guiding tumor resection.
We have previously used a VWF blue laser system with fluorescein, and other fluorescent dyes that are not approved for human use, in the setting of a murine malignant glioma. 19 Currently, fluorescein is the only clinically approved fluorescent agent used for VWF endomicroscopy, and we have begun evaluating the use of such a system during resection of human intracranial tumors.
18,19
Many of the fluorophores used in visible-wavelength laser confocal technology for imaging other body regions, such as the gastrointestinal tract (for example, cresyl violet, acridine orange, and acriflavine), are not approved for use in the brain because they are mutagens. Therefore, at this time the choice of these staining agents in a VWF laser confocal instrument is limited to fluorescein administration in the brain, although 5-ALA tumor incorporation can be visualized using such a system.
Fluorescein is a predominantly extracellular contrast agent, penetrating only the disrupted BBB. Thus, in malignant gliomas it provides intense fluorescent background. Cells, intracellular structures, debris, and processes are identified as transparent patterns or darker structures against the fluorescing background.
19 Erythrocytes are also imaged against the background. Unless cleaned from the probe lens, artifacts from blood can decrease image quality and affect analysis.
The NIR system may represent a significant alternative to VWF in vivo endomicroscopy. The results of our study showed that ICG requires disruption of the BBB to penetrate vessels to stain tumor cells and neighboring brain tissue. Indocyanine green is an intracellular contrast agent, which binds to cytoplasmic proteins, providing visualization of features such as nuclei and cytoplasmic inclusions on a subcellular level (Table 1) . Atypical pleomorphic cells and mitotic figures were clearly identified within the image. The nuclear/cytoplasmic ratio, which is an important diagnostic feature, could be easily assessed. Nonfluorescent regions within obvious tumor tissue were interpreted as areas of necrosis. Abnormal and normal microscopic vessels, including tumor microvasculature, were clearly observed. Digital images rapidly acquired in sequence could be constructed into video loops for a nearly immediate review of the associations among tumor cells, surrounding brain tissue, and vasculature. Increased depth of imaging offers high-resolution images up to 350 μm in depth, nearly twice the depth offered by VWF.
Indocyanine Green Fluorescence
Indocyanine green is an NIR fluorescent tricarbocyanine dye (C 43 H 47 N 2 NaO 6 S 2 ). With absorption and emission peaks between 805 and 835 nm, respectively, the dye lies within the "optical window" of tissue, where absorption attributable to endogenous chromophores is low. 4, 6 After intravenous injection of ICG, the dye binds almost completely to globulins, preferentially to a 1 -lipoproteins, within 1 to 2 seconds. 2 When normal vascular permeability is preserved, the dye remains in the intravascular compartment. With a plasma half-life of 3-4 minutes, after 10 minutes, only a small fraction of the originally injected ICG volume can be detected in the blood. The dye is not metabolized in the body, and hepatic elimination is the main source of clearance.
Indocyanine green has been used extensively in retinal angiography and, more recently, in the intraoperative assessment of blood flow and patency during cerebrovascular surgery. 16 The usual dose for video angiography ranges from 0.2 to 0.5 mg/kg, and the total daily dose should not exceed 5 mg/kg. 16 In our study, all mice received a standard dose of 0.4 mg/kg ICG (Akorn, Inc.) administered intravenously into the tail vein immediately after the brain convexity was exposed. Our results suggest that ICG fluorescence of tumor cells is time dependent, providing a higher signal 15 minutes after injection than immediately after ICG administration. We have not conducted timing experiments that would provide data to suggest the average period of fluorescence after a single administration of ICG. However, we were able to detect bright fluorescent signal after 1 hour of continuous imaging. This finding suggests that as soon as ICG saturates tumor cells it retains fluorescent properties even after continuous exposure of near-infrared laser, without fading. This feature would be a potential advantage in comparison with visible-wavelength fluorophores, which tend to fade after a brief exposure to light or laser.
Indocyanine green is approved for and used routinely in cerebrovascular surgery. Its use appears to be associated with far fewer risks compared with fluorescein. Therefore, its application in human surgery is likely to be relatively straightforward. 13 Unlike fluorescein, which provides immediate fluorescence, ICG injections are time dependent. Thus, optimally ICG should be administered at least 15 minutes before imaging. Interestingly, ICG fluorescence was detected in areas of surgical trauma. This observation most likely reflects extravasation of ICG from damaged vessels. This feature may mean that ICG administration for NIR imaging might be useful during resection of benign gliomas, where the BBB is relatively intact. During resection of benign lesions, fluorescence might be achieved as a result of ICG leaking from disrupted tumor vessels and thereby being incorporated into the tumor cells and potentially delineating the tumor region. Near-infrared confocal endomicroscopy with ICG provides striking distinguishing features of normal brain and tumor regions, potentially providing information about the border on the histological magnification.
Potential Technology Impact on Glioma Resection
Multiple clinical studies have shown that more aggressive resection of malignant tumors improves patient survival. 1, 5, 14, 15, 17, 27 However, the extent of resection is limited to gross estimation of the tumor boundaries. Such technologies as image-guided surgical systems that provide intraoperative navigation are routinely used for intracranial tumor resection. However, intraoperative shifting of the intracranial contents distorts the anatomical image registration. Thus, techniques that might allow intraoperative delineation of the extent of the tumor have been used, including ultrasonography, intraoperative MR imaging, and 5-ALA fluorescence-guided surgery. These techniques appear to improve estimation of tumor margins and may lead to more extensive resection. However, none of these techniques provides microscopic identification of tumor cells and the infiltrative tumor margin.
Examining the entire tumor margin or the entire resection bed of the tumor with the confocal endomicroscope may not be possible or practical. The confocal endomicroscope provides a 475 × 475-μm FOV. Therefore, it would be time consuming to scan a large surface area of a brain tumor, although certainly more efficient and economical than equivalent efforts at frozen section. Reaching deep or remote regions of the operating field might be challenging as well. Furthermore, there is no guarantee that images will be useful, although such digital imaging showing microscopic histoarchitecture would be immediate. Nonetheless, this technique has the potential to help improve tumor resection compared with current intraoperative methods in relatively restricted areas or in regions where tumor infiltration is suspected. The definitive impact on resection and survival will await application of the confocal technology in an appropriate clinical trial scenario.
The technology provides an instantaneous, real-time intraoperative view of histopathological features. Perhaps with development and familiarity, it will be possible to eliminate some frozen sections, or at least to guide the selection of locations for obtaining frozen sections, thereby improving diagnostic yield or acquisition efficiency, as it has in gastrointestinal endoscopic surveys. The ability to assess multiple brain tumor regions in a relatively short period seems encouraging.
A learning curve is associated with using this technique and with interpreting confocal images. It requires experience to operate the device to acquire a minimal number of informative confocal images from each ROI. The skills to distinguish normal brain from tumor require experience in the analysis of multiple confocal images; however, our experience with this animal tumor model indicates that this skill can be successfully achieved by neurosurgeons. The uptake in what might be injured areas of the brain is worth noting, although with use and experience the surgeon should have a good idea of which areas are traumatic and which are high suspects for tumor. In addition, the images should show the tissue characteristics of tumor. Providing intraoperative histopathological diagnosis, including tumor grading, will require further involvement of an experienced neuropathologist to analyze and compare multiple confocal images with traditional histological sections. We believe such technology has the potential to impact the surgical/pathology tissue analysis workflow, and it may be that neurosurgeons might gain increased familiarity with histological features.
Fluorescent endomicroscopic confocal technology should not be viewed as a replacement for permanent histological analysis. However, it represents a significant tool adapted for the ergonomic dimensions of human brain surgery that can be used in vivo to visualize cells. 18, 19 Such fluorescent imaging provides observation of other dimensions of cellular characteristics compared with permanent histological specimens, and probably can be used with refinement to select the optimal locations to harvest tissue for histological analysis. The NIR adaptation of this instrument is critical because it can take advantage of the application of at least one fluorophore that is well incorporated into a form of cancer that poses a significant challenge (that is, malignant glial tissue) and is a dye that has been used conveniently in neurosurgery, with a safe record. With further investigation, alternative fluorophores, including fluorescent antibodies, may allow in vivo assessment of cellular treatments of tumors in the NIR spectrum. Notably, we have imaged cells labeled with 5-ALA with the VWF blue laser system, but such cell labeling is not detected using the NIR spectrum. Combining different wavelength technologies, such as VWF confocal endomicroscopy using fluorescein, may allow many different dimensional characteristics of the nature of cancer to be assayed in vivo in the human brain while improving the surgeon's ability to resect tumors.
Conclusions
Macroscopic fluorescence was effective for gross tumor detection, but NIR confocal endomicroscopy with ICG fluorescence greatly enhanced the sensitivity of the macroscopic observations and provided real-time in vivo microhistological information precisely related to the site of imaging. Individual tumor cells within brain tissue were identified, and a definitive tumor border was delimited. This is the first time that such NIR microscopic technology using ICG has been used in vivo in the detection of cancer, and it provided important histological information about tumor regions, normal brain, and transitional zones. Further investigations are required to define the optimal role of this technology in the setting of intraoperative brain tumor diagnosis and guidance of resection.
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